$4.94
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
AVITA Medical to Announce Second Quarter 2026 Financial Results
AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum
Avita Medical (RCEL) Upgraded to Buy: Here's Why
Overview
52-week range
$3.22
$7.12
44% of range
Avg surprise (last 3)
-27.3%
Avg reaction (last 2)
+0.4%
50% positive
Latest IV / EM
122%
EM ±27.8% · $5 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.35 | $-0.35 | 0.0% | +34.0% | +2.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.46 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.38 | $-0.26 | -46.1% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.53 | $-0.39 | -35.9% | — | -1.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.62 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.60 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.73 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.34 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.41 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | AMC | — | -$0.38 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | — | $17M | $18M | $19M | — | $20M | $15M |
| Cost of revenue | $4M | — | $3M | $3M | $3M | — | $3M | $2M |
| Gross profit | $16M | — | $14M | $15M | $16M | — | $16M | $13M |
| Operating income | $-9M | — | $-9M | $-11M | $-12M | — | $-14M | $-16M |
| Net income | $-11M | — | $-13M | $-10M | $-14M | — | $-16M | $-15M |
| EPS (diluted) | $-0.35 | — | $-0.46 | $-0.38 | $-0.53 | — | $-0.62 | $-0.60 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8M | $10M | $15M | $12M | $15M | $14M | $19M | $17M |
| Inventory | $6M | $7M | $7M | $8M | $8M | $7M | $6M | $7M |
| Total current assets | $32M | $35M | $41M | $36M | $48M | $57M | $64M | $73M |
| Total assets | $52M | $56M | $64M | $58M | $70M | $80M | $81M | $88M |
| Long-term debt | — | — | $0 | $42M | $41M | $42M | $43M | $41M |
| Total liabilities | $75M | $73M | $70M | $71M | $74M | $75M | $69M | $64M |
| Total equity | $-23M | $-17M | $-7M | $-13M | $-5M | $4M | $12M | $24M |